Arcutis Biotherapeutics Inc. (ARQT) Social Stream
ARCUTIS BIOTHERAPEUTICS INC (ARQT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ARCUTIS BIOTHERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $80 | $48 | $57.2 | $5.31 | 977.21% |
| 2022-02-03 | 4 | $80 | $35 | $54.2 | $5.31 | 920.72% |
| 2022-02-24 | 5 | $80 | $35 | $54.2 | $5.31 | 920.72% |
| 2022-03-02 | 5 | $80 | $37 | $54.6 | $5.31 | 928.25% |
| 2022-04-07 | 5 | $80 | $37 | $54.4 | $5.31 | 924.48% |
| 2022-05-10 | 5 | $80 | $36 | $54.2 | $5.31 | 920.72% |
| 2022-05-23 | 6 | $80 | $36 | $52.666 | $5.31 | 891.83% |
| 2022-06-07 | 6 | $80 | $39 | $53.166 | $5.31 | 901.24% |
| 2022-08-01 | 5 | $80 | $39 | $53.5 | $5.31 | 907.53% |
| 2022-08-02 | 5 | $80 | $45 | $54.5 | $5.31 | 926.37% |
| 2022-08-19 | 5 | $80 | $45 | $55.333 | $5.31 | 942.05% |
| 2022-09-07 | 6 | $80 | $45 | $54 | $5.31 | 916.95% |
| 2022-09-27 | 7 | $80 | $45 | $54.571 | $5.31 | 927.7% |
| 2022-11-02 | 7 | $80 | $46 | $55.142 | $5.31 | 938.46% |
| 2022-11-10 | 7 | $80 | $46 | $55.142 | $5.31 | 938.46% |
| 2023-01-23 | 7 | $80 | $46 | $55.428 | $5.31 | 943.84% |
| 2023-03-02 | 6 | $80 | $46 | $55.285 | $5.31 | 941.15% |
| 2023-04-05 | 7 | $80 | $45 | $54.571 | $5.31 | 927.7% |
| 2023-04-12 | 7 | $80 | $45 | $54.142 | $5.31 | 919.62% |
| 2023-04-19 | 7 | $80 | $24 | $51 | $5.31 | 860.45% |
| 2023-04-24 | 7 | $80.001 | $24 | $51 | $5.31 | 860.45% |
| 2023-05-11 | 6 | $65 | $24 | $45.666 | $5.31 | 760% |
| 2023-05-26 | 7 | $65 | $24 | $44.857 | $5.31 | 744.76% |
| 2023-08-08 | 6 | $65 | $24 | $44.571 | $5.31 | 739.38% |
| 2023-08-10 | 5 | $50 | $22 | $39.666 | $5.31 | 647.01% |
The Trend in the Analyst Price Target
Over the past 15 months, ARQT's average price target has gone down $12.06.
ARQT reports an average of 295.6% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-11 | 7 | 80 | 46 | 55.142 | 18.53 | 197.58% |
| 2022-11-02 | 7 | 80 | 46 | 55.142 | 17.58 | 213.66% |
| 2023-04-19 | 7 | 80 | 24 | 51.000 | 13.59 | 275.28% |
| 2023-05-11 | 7 | 65 | 24 | 45.571 | 10.83 | 320.78% |
| 2023-08-08 | 6 | 65 | 24 | 44.571 | 9.83 | 353.42% |
ARQT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 21 months, ARQT's average broker recommendation rating improved by 0.03.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ARCUTIS BIOTHERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3264.21% of that group.
- In terms of how ARCUTIS BIOTHERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3091.43% of that group.
- ARQT has a lower variance in analysts' estimates than -2400.6% of stocks in the small market cap category.
- ARQT has a greater number of analysts covering the stock than 2383.24% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ANVS, ETNB, and GRTX are the three stocks most similar to ARCUTIS BIOTHERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ARQT? Use POWR Ratings for clearer insight into price direction.